Armata Pharmaceuticals, Inc. Common Stock (ARMP) R&D to Revenue & History | Stock Alarm

Demo Sign up Log In

Armata Pharmaceuticals, Inc. Common Stock · R&D to Revenue

ARMP R&D to Revenue

Latest reported483.63%period endingDec 31, 2025

ARMP FY R&D/Revenue (0.00% → 483.63%)

Latest values, visible window

High-resolution chart · PNG

ARMP r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Armata Pharmaceuticals, Inc. Common Stock R&D to Revenue — Annual fiscal periods
Period ending	R&D to Revenue
Dec 31, 2025	483.6256%
Dec 31, 2024	665.3653%
Dec 31, 2023	745.6392%
Dec 31, 2022	635.748%
Dec 31, 2021	447.3625%
Dec 31, 2020	1,755.0425%
Dec 31, 2019	0%
Dec 31, 2018	0%
Dec 31, 2017	2,505.2174%
Dec 31, 2016	2,183.8462%
Dec 31, 2015	840.4211%
Dec 31, 2014	1,419.3154%
Dec 31, 2013	2,000.6154%
Dec 31, 2012	222.8916%
Dec 31, 2009	0%
Dec 31, 2008	174.1569%
Dec 31, 2007	171.3995%
Dec 31, 2006	146.8167%
Dec 31, 2005	264.7512%
Dec 31, 2004	179.1131%
Dec 31, 2003	122.1985%
Dec 31, 2002	152.0147%
Dec 31, 2001	167.0869%
Dec 31, 2000	169.3589%
Dec 31, 1999	210.2941%
Dec 31, 1998	184.7222%
Dec 31, 1997	1,444.4444%
Dec 31, 1996	500%
Dec 31, 1995	8,200%
Dec 31, 1994	1,700%
Dec 31, 1993	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.